T1	Subjective_judgement 3 152	Currently enrolled in another research trial for investigative nutritional or other therapies thought to have an impact on immune system functioning.
T2	Post-eligibility 3 152	Currently enrolled in another research trial for investigative nutritional or other therapies thought to have an impact on immune system functioning.
T3	Post-eligibility 157 188	Unable to consent to the study.
T4	Non-query-able 157 188	Unable to consent to the study.
T5	Person 193 198	Women
T6	Condition 207 215	pregnant
T7	Condition 299 319	spontaneous abortion
T8	Temporal 289 298	recurrent
R1	Has_temporal Arg1:T7 Arg2:T8	
T9	Condition 423 435	heart attack
T10	Temporal 416 422	recent
R2	Has_temporal Arg1:T9 Arg2:T10	
T11	Condition 439 445	stroke
T12	Condition 449 471	chronic kidney disease
*	OR T12 T11 T9
T13	Drug 494 521	immunomodulatory medication
T14	Undefined_semantics 494 521	immunomodulatory medication
T15	Drug 528 538	interferon
R3	Subsumes Arg1:T13 Arg2:T15	
T16	Drug 641 664	chemotherapeutic agents
T17	Undefined_semantics 641 664	chemotherapeutic agents
T18	Condition 676 691	allergy to rice
T19	Drug 687 691	rice
R4	AND Arg1:T18 Arg2:T19	
T20	Condition 676 686;693 702	allergy to rice bran
T21	Drug 693 702	rice bran
R5	AND Arg1:T20 Arg2:T21	
T22	Undefined_semantics 707 728	related food products
T23	Condition 740 760	allergy to mushrooms
T24	Condition 802 814	malignancies
T25	Observation 791 798	History
T26	Qualifier 815 842	related to the NK cell line
T27	Condition 855 872	NK cell leukemias
T28	Condition 877 919	T-cell large granular lymphocyte leukemias
T29	Grammar_Error 873 876	and
T30	Condition 921 980	NK-cell lymphoproliferative disease of granular lymphocytes
T31	Condition 986 1003	NK cell lymphomas
T32	Condition 1021 1051	nasal-like NK/T-cell lymphomas
T33	Condition 1011 1016;1032 1051	nasal NK/T-cell lymphomas
T34	Grammar_Error 1017 1020	and
*	OR T33 T32 T31 T30 T28 T27
T35	Grammar_Error 982 985	and
T36	Scope 855 1051	NK cell leukemias and T-cell large granular lymphocyte leukemias, NK-cell lymphoproliferative disease of granular lymphocytes, and NK cell lymphomas, e.g., nasal and nasal-like NK/T-cell lymphomas
*	OR T24 T26
T37	Scope 802 842	malignancies related to the NK cell line
R6	Subsumes Arg1:T37 Arg2:T36	
R7	Has_temporal Arg1:T37 Arg2:T25	
T38	Qualifier 325 330	Other
T39	Condition 331 352	medical complications
R8	Has_qualifier Arg1:T39 Arg2:T38	
T40	Negation 364 372	preclude
T41	Informed_consent 382 408	participating in the study
R9	Has_negation Arg1:T41 Arg2:T40	
R10	AND Arg1:T39 Arg2:T41	
T42	Scope 325 408	Other medical complications that might preclude one from participating in the study
T43	Scope 416 471	recent heart attack or stroke or chronic kidney disease
R11	Has_scope Arg1:T42 Arg2:T43	
T44	Temporal 544 553	Currently
T45	Qualifier 561 566	other
T46	Drug 567 578	medications
T47	Qualifier 598 633	impact on immune system functioning
R12	Has_qualifier Arg1:T46 Arg2:T45	
R13	Has_qualifier Arg1:T46 Arg2:T47	
T48	Scope 561 633	other medications thought to have an impact on immune system functioning
R14	Subsumes Arg1:T46 Arg2:T16	
R15	Has_temporal Arg1:T48 Arg2:T44	
T49	Condition 740 750;772 785	allergy to food products
*	OR T49 T23
T50	Temporal 1058 1065	Current
T51	Observation 1066 1072	smoker
R16	Has_temporal Arg1:T51 Arg2:T50	
